TCF12 is mutated in anaplastic oligodendroglioma

Autor: Labreche, Karim, Simeonova, Iva, Kamoun, Aurélie, Gleize, Vincent, Chubb, Daniel, Letouzé, Eric, Riazalhosseini, Yasser, Dobbins, Sara E., Elarouci, Nabila, Ducray, Francois, De Reyniès, Aurélien, Zelenika, Diana, Wardell, Christopher P., Frampton, Mathew, Saulnier, Olivier, Pastinen, Tomi, Hallout, Sabrina, Figarella-Branger, Dominique, Dehais, Caroline, Idbaih, Ahmed, Mokhtari, Karima, Delattre, Jean-Yves, Huillard, Emmanuelle, Lathrop, G Mark, Sanson, Marc, Houlston, Richard S.

Publikováno v: Nature Communications
Nature Communications, Nature Publishing Group, 2015, 6, pp.7207. ⟨10.1038/ncomms8207⟩
Nature Communications, 2015, 6, pp.7207. ⟨10.1038/ncomms8207⟩

Anaplastic oligodendroglioma (AO) are rare primary brain tumours that are generally incurable, with heterogeneous prognosis and few treatment targets identified. Most oligodendrogliomas have chromosomes 1p/19q co-deletion and an IDH mutation. Here we

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::30f083c6ccfeff6adfbb282291ffb979
https://hal.sorbonne-universite.fr/hal-01295222

Corrigendum to “Retrospective multicenter study by the French Spine Society of surgical treatment for spinal metastasis in France” [Orthop Traumatol Surg Res 104 (2018) 589–95]

Autor: Sailhan, Frédéric, Prost, Solène, Hallout, Sabrina, Zairi, Fahed, Gille, Olivier, Pascal-Mousselard, Hughes, Bennis, Saad, Charles, Yann-Philippe, Blondel, Benjamin, Fuentes, Stéphane

Publikováno v: In Orthopaedics & Traumatology: Surgery & Research May 2019 105(3):575-575

TCF12 is mutated in anaplastic oligodendroglioma.

Autor: Labreche K; 1] Division of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK [2] Inserm, U 1127, ICM, F-75013 Paris, France [3] CNRS, UMR 7225, ICM, F-75013 Paris, France [4] Institut du Cerveau et de la Moelle épinière ICM, Paris 75013, France [5] Sorbonne Universités, UPMC Université Paris 06, UMR S 1127, F-75013 Paris, France., Simeonova I; 1] Inserm, U 1127, ICM, F-75013 Paris, France [2] CNRS, UMR 7225, ICM, F-75013 Paris, France [3] Institut du Cerveau et de la Moelle épinière ICM, Paris 75013, France [4] Sorbonne Universités, UPMC Université Paris 06, UMR S 1127, F-75013 Paris, France., Kamoun A; Programme Cartes d'Identité des Tumeurs (CIT), Ligue Nationale Contre Le Cancer, 75013 Paris, France., Gleize V; 1] Inserm, U 1127, ICM, F-75013 Paris, France [2] CNRS, UMR 7225, ICM, F-75013 Paris, France [3] Institut du Cerveau et de la Moelle épinière ICM, Paris 75013, France [4] Sorbonne Universités, UPMC Université Paris 06, UMR S 1127, F-75013 Paris, France., Chubb D; Division of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK., Letouzé E; Programme Cartes d'Identité des Tumeurs (CIT), Ligue Nationale Contre Le Cancer, 75013 Paris, France., Riazalhosseini Y; 1] Department of Human Genetics, McGill University, Montreal, Quebec, Canada H3A 0G1 [2] McGill University and Genome Quebec Innovation Centre, Montreal, Quebec, Canada H3A 0G1., Dobbins SE; Division of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK., Elarouci N; Programme Cartes d'Identité des Tumeurs (CIT), Ligue Nationale Contre Le Cancer, 75013 Paris, France., Ducray F; INSERM U1028, CNRS UMR5292, Service de Neuro-oncologie, Hopital neurologique, Hospices civils de Lyon, Lyon Neuroscience Research Center, Neuro-Oncology and Neuro-Inflammation Team, 69677 Lyon, France., de Reyniès A; Programme Cartes d'Identité des Tumeurs (CIT), Ligue Nationale Contre Le Cancer, 75013 Paris, France., Zelenika D; Centre National de Génotypage, IG/CEA, 2 rue Gaston Crémieux, CP 5721, Evry 91057, France., Wardell CP; Division of Molecular Pathology, The Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK., Frampton M; Division of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK., Saulnier O; 1] Inserm, U 1127, ICM, F-75013 Paris, France [2] CNRS, UMR 7225, ICM, F-75013 Paris, France [3] Institut du Cerveau et de la Moelle épinière ICM, Paris 75013, France [4] Sorbonne Universités, UPMC Université Paris 06, UMR S 1127, F-75013 Paris, France., Pastinen T; 1] Department of Human Genetics, McGill University, Montreal, Quebec, Canada H3A 0G1 [2] McGill University and Genome Quebec Innovation Centre, Montreal, Quebec, Canada H3A 0G1., Hallout S; 1] Inserm, U 1127, ICM, F-75013 Paris, France [2] CNRS, UMR 7225, ICM, F-75013 Paris, France [3] Institut du Cerveau et de la Moelle épinière ICM, Paris 75013, France., Figarella-Branger D; 1] AP-HM, Hôpital de la Timone, Service d'anatomie pathologique et de neuropathologie, 13385 Marseille, France [2] Université de la Méditerranée, Aix-Marseille, Faculté de Médecine La Timone, CRO2, UMR 911 Marseille, France., Dehais C; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de neurologie 2-Mazarin, 75013 Paris, France., Idbaih A; 1] Inserm, U 1127, ICM, F-75013 Paris, France [2] CNRS, UMR 7225, ICM, F-75013 Paris, France [3] Institut du Cerveau et de la Moelle épinière ICM, Paris 75013, France [4] Sorbonne Universités, UPMC Université Paris 06, UMR S 1127, F-75013 Paris, France [5] AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de neurologie 2-Mazarin, 75013 Paris, France., Mokhtari K; 1] Inserm, U 1127, ICM, F-75013 Paris, France [2] CNRS, UMR 7225, ICM, F-75013 Paris, France [3] Institut du Cerveau et de la Moelle épinière ICM, Paris 75013, France [4] AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Laboratoire de Neuropathologie R. Escourolle, 75013 Paris, France., Delattre JY; 1] Inserm, U 1127, ICM, F-75013 Paris, France [2] CNRS, UMR 7225, ICM, F-75013 Paris, France [3] Institut du Cerveau et de la Moelle épinière ICM, Paris 75013, France [4] Sorbonne Universités, UPMC Université Paris 06, UMR S 1127, F-75013 Paris, France [5] AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de neurologie 2-Mazarin, 75013 Paris, France., Huillard E; 1] Inserm, U 1127, ICM, F-75013 Paris, France [2] CNRS, UMR 7225, ICM, F-75013 Paris, France [3] Institut du Cerveau et de la Moelle épinière ICM, Paris 75013, France [4] Sorbonne Universités, UPMC Université Paris 06, UMR S 1127, F-75013 Paris, France., Mark Lathrop G; 1] Department of Human Genetics, McGill University, Montreal, Quebec, Canada H3A 0G1 [2] McGill University and Genome Quebec Innovation Centre, Montreal, Quebec, Canada H3A 0G1., Sanson M; 1] Inserm, U 1127, ICM, F-75013 Paris, France [2] CNRS, UMR 7225, ICM, F-75013 Paris, France [3] Institut du Cerveau et de la Moelle épinière ICM, Paris 75013, France [4] Sorbonne Universités, UPMC Université Paris 06, UMR S 1127, F-75013 Paris, France [5] AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de neurologie 2-Mazarin, 75013 Paris, France., Houlston RS; Division of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK.

Publikováno v: Nature communications [Nat Commun] 2015 Jun 12; Vol. 6, pp. 7207. Date of Electronic Publication: 2015 Jun 12.